That a stage 2/3 successfully TGA/FDA/EMA approved company on the verge of more approvals and a possible partnership with the largest pharma company in the world is trading $100 million is absurd. It will come guys. A little more patience to the next huge milestone of J&J 4 year collaborative trial results this quarter. If a partnership is announced a year from now you will have forgotten all of this frustration.
Ann: Orthocell Appoints Exclusive Distributor in Australia, page-48
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.5¢ |
Change
-0.020(2.92%) |
Mkt cap ! $159.0M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 65.0¢ | $245.7K | 371.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15000 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 66.5¢ | 12621 | 2 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| OCC (ASX) Chart |